Quince Therapeutics, Inc. Research And Development Expense

• Quince Therapeutics, Inc. showed an increase of +96.8% in Research And Development Expense from 2023 to 2024.
• This data is from Quince Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), Quince Therapeutics, Inc.'s Research And Development Expense has grown by 84.3%.
• Historical annual values: Fiscal year 2024: $18.59 million | Fiscal year 2023: $9.45 million | Fiscal year 2022: $25.18 million | Fiscal year 2021: $60.80 million | Fiscal year 2020: $61.31 million | Fiscal year 2019: $30.21 million | Fiscal year 2018: $10.09 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026